Mackenzie Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $449M | Sell |
2,065,016
-11,146
| -0.5% | -$2.47M | 0.54% | 42 |
|
|
2025
Q4 | $476M | Sell |
2,076,162
-161,935
| -7% | -$36.9M | 0.56% | 36 |
|
|
2025
Q3 | $518M | Sell |
2,238,097
-99,604
| -4% | -$20.3M | 0.63% | 33 |
|
|
2025
Q2 | $434M | Sell |
2,337,701
-162,035
| -6% | -$30.1M | 0.56% | 44 |
|
|
2025
Q1 | $524M | Buy |
2,499,736
+62,437
| +3% | +$12.1M | 0.74% | 35 |
|
|
2024
Q4 | $433M | Buy |
2,437,299
+109,046
| +5% | +$20M | 0.59% | 46 |
|
|
2024
Q3 | $460M | Buy |
2,328,253
+20,890
| +0.9% | +$3.9M | 0.64% | 41 |
|
|
2024
Q2 | $396M | Buy |
2,307,363
+227,957
| +11% | +$37.8M | 0.59% | 42 |
|
|
2024
Q1 | $379M | Buy |
2,079,406
+260,556
| +14% | +$44.9M | 0.55% | 45 |
|
|
2023
Q4 | $282M | Buy |
1,818,850
+195,901
| +12% | +$28.6M | 0.43% | 62 |
|
|
2023
Q3 | $239M | Sell |
1,622,949
-13,029
| -0.8% | -$1.91M | 0.4% | 66 |
|
|
2023
Q2 | $221M | Sell |
1,635,978
-95,033
| -5% | -$13.9M | 0.34% | 74 |
|
|
2023
Q1 | $276M | Sell |
1,731,011
-116,130
| -6% | -$17.8M | 0.43% | 58 |
|
|
2022
Q4 | $299M | Sell |
1,847,141
-75,158
| -4% | -$11.5M | 0.5% | 48 |
|
|
2022
Q3 | $258M | Sell |
1,922,299
-37,904
| -2% | -$5.44M | 0.44% | 54 |
|
|
2022
Q2 | $300M | Buy |
1,960,203
+30,757
| +2% | +$4.7M | 0.48% | 48 |
|
|
2022
Q1 | $313M | Buy |
1,929,446
+9,892
| +0.5% | +$1.44M | 0.42% | 55 |
|
|
2021
Q4 | $260M | Sell |
1,919,554
-547,873
| -22% | -$64.7M | 0.35% | 71 |
|
|
2021
Q3 | $266M | Sell |
2,467,427
-121,276
| -5% | -$13.9M | 0.38% | 66 |
|
|
2021
Q2 | $292M | Buy |
2,588,703
+110,542
| +4% | +$12.4M | 0.41% | 64 |
|
|
2021
Q1 | $268M | Buy |
2,478,161
+216,889
| +10% | +$23.2M | 0.41% | 62 |
|
|
2020
Q4 | $242M | Buy |
2,261,272
+1,246,737
| +123% | +$120M | 0.52% | 50 |
|
|
2020
Q3 | $88.9M | Buy |
1,014,535
+729,594
| +256% | +$68.7M | 0.22% | 125 |
|
|
2020
Q2 | $28M | Buy |
284,941
+4,716
| +2% | +$415K | 0.07% | 207 |
|
|
2020
Q1 | $21.4M | Sell |
280,225
-444,899
| -61% | -$37.9M | 0.07% | 209 |
|
|
2019
Q4 | $64.2M | Sell |
725,124
-193,659
| -21% | -$16.1M | 0.16% | 149 |
|
|
2019
Q3 | $69.6M | Sell |
918,783
-522,594
| -36% | -$35.8M | 0.18% | 136 |
|
|
2019
Q2 | $105M | Buy |
1,441,377
+1,313,089
| +1,024% | +$103M | 0.27% | 92 |
|
|
2019
Q1 | $10.3M | Sell |
128,288
-120,623
| -48% | -$9.87M | 0.02% | 364 |
|
|
2018
Q4 | $22.9M | Buy |
248,911
+144,880
| +139% | +$12.7M | 0.06% | 230 |
|
|
2018
Q3 | $9.84M | Sell |
104,031
-3,455
| -3% | -$328K | 0.02% | 335 |
|
|
2018
Q2 | $9.96M | Sell |
107,486
-464,032
| -81% | -$45.3M | 0.03% | 328 |
|
|
2018
Q1 | $54.1M | Sell |
571,518
-189,554
| -25% | -$20.8M | 0.14% | 157 |
|
|
2017
Q4 | $73.6M | Buy |
761,072
+403,868
| +113% | +$38.1M | 0.18% | 120 |
|
|
2017
Q3 | $31.7M | Sell |
357,204
-133,744
| -27% | -$10.2M | 0.17% | 147 |
|
|
2017
Q2 | $35.6M | Sell |
490,948
-47,724
| -9% | -$3.21M | 0.2% | 129 |
|
|
2017
Q1 | $35.1M | Sell |
538,672
-86,542
| -14% | -$5.44M | 0.21% | 126 |
|
|
2016
Q4 | $39.2M | Buy |
625,214
+61,841
| +11% | +$3.77M | 0.23% | 122 |
|
|
2016
Q3 | $35.5M | Sell |
563,373
-39,060
| -6% | -$2.53M | 0.22% | 122 |
|
|
2016
Q2 | $37.3M | Buy |
602,433
+52,174
| +9% | +$3.18M | 0.21% | 124 |
|
|
2016
Q1 | $31.4M | Buy |
550,259
+93,507
| +20% | +$5.21M | 0.29% | 91 |
|
|
2015
Q4 | $27.1M | Buy |
456,752
+399,789
| +702% | +$23M | 0.17% | 139 |
|
|
2015
Q3 | $3.1M | Buy |
56,963
+39,179
| +220% | +$2.55M | 0.02% | 342 |
|
|
2015
Q2 | $1.2M | Hold |
17,784
| – | – | 0.01% | 527 |
|
|
2015
Q1 | $1.04M | Sell |
17,784
-22,100
| -55% | -$1.34M | 0.01% | 540 |
|
|
2014
Q4 | $2.61M | Buy |
39,884
+2,100
| +6% | +$132K | 0.01% | 393 |
|
|
2014
Q3 | $2.18M | Buy |
37,784
+19,358
| +105% | +$1.07M | 0.01% | 391 |
|
|
2014
Q2 | $1.04M | Buy |
18,426
+2,642
| +17% | +$139K | ﹤0.01% | 501 |
|
|
2014
Q1 | $811K | Sell |
15,784
-118,400
| -88% | -$5.98M | ﹤0.01% | 535 |
|
|
2013
Q4 | $7.09M | Buy |
134,184
+124,400
| +1,271% | +$6.11M | 0.04% | 272 |
|
|
2013
Q3 | $438K | Hold |
9,784
| – | – | ﹤0.01% | 576 |
|
|
2013
Q2 | $404K | Buy |
+9,784
| New | +$428K | ﹤0.01% | 598 |
|
Other funds holding ABBV
VCM
VPM
Mackenzie Financial's ABBV Position: Q1 2026 in Review
Mackenzie Financial reduced its AbbVie (ABBV) stake by 0.54% in Q1 2026, selling an estimated $2.47M and leaving 2,065,016 shares worth $449M. The position accounts for 0.54% of the portfolio, ranked #42.
Mackenzie Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $524M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Mackenzie Financial held 2,065,016 shares of AbbVie worth $449M as of Q1 2026.
- Mackenzie Financial sold 11,146 AbbVie shares in Q1 2026, an estimated $2.47M.
- AbbVie made up 0.54% of Mackenzie Financial's portfolio in Q1 2026, its #42 holding.
- Mackenzie Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Mackenzie Financial's AbbVie position peaked at $524M in Q1 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.